MiniMed Group's first quarter 2027 revenue reached $843M as U.S. pump sales grew 20%

MiniMed Group reported a strong start to fiscal year 2027 with net sales of $843 million, representing 17% reported growth. Results were supported by a 4-6% benefit from an extra week in the fiscal calendar and the successful U.S. rollout of the MiniMed Flex system, which drove double-digit organic growth even when excluding the calendar benefit.

Key Highlights

• U.S. New Pumps Sold (NPS) accelerated to over 20% growth year-over-year, significantly higher than the total worldwide NPS growth of 7.7%.
• Management raised fiscal year 2027 organic revenue growth guidance to 10.5% from 10.0%, while reaffirming a 16% Adjusted EBITDA margin.
• The global CGM attachment rate improved by approximately 100 basis points sequentially to 69%, driven by the Simplera capacity expansion.